• “Method of Treating Leishmaniasis using Methyl-beta-cyclodextrin" (U.S. patent # 7186702, awarded March 6, 2007).

• “A Composition useful for the Treatment of Leishmaniasis” (Indian patent # 242180, awarded August 18, 2010).